ImCheck Announces First Patients Dosed in Phase II of EVICTION Trial for ICT01

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

France ,Marseille Immunopole ,Institut Paoli Calmettes ,Gretchen Schweitzer ,Marseille Universit ,Trophic Communications ,Imcheck Announces First Patients Dosed ,Imcheck Therapeutics ,Chief Executive Officer ,Neck Squamous Cell Carcinoma ,Daniel Olive ,Aix Marseille Universit ,Health ,Business ,Globe Newswire ,Cancer ,Tumors ,Europe ,Clinical Trials ,